• TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • 5-HT Receptor
    (1)
  • COX
    (1)
  • HIV Protease
    (1)
  • Others
    (4)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 35日内发货
    (1)
  • 6-8周
    (4)
  • 3-6月
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "vt-101"的结果
筛选
搜索结果
TargetMol产品目录中 "

vt-101

"的结果
  • 抑制剂&激动剂
    7
    TargetMol | Inhibitors_Agonists
  • 多肽产品
    1
    TargetMol | Peptide_Products
  • 同位素
    1
    TargetMol | Isotope_Products
  • VT101 free base
    T6893465194-64-1
    VT101 is a TEAD Auto-palmitoylation inhibitor that Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. VT101 inhibited the firefly luciferase reporter dose-dependently and had no 204 effect on the Renilla luciferase reporter.
    • ¥ 10600
    6-8周
    规格
    数量
  • EVT-101 free base
    T68973627525-33-1
    EVT-101, also known as ENS-101, is an experimental medication which originated from Roche and is under development by Evotec AG for the treatment of major depressive disorder. It acts as a selective NMDA receptor subunit 2B (NR2B) antagonist.
    • ¥ 58000
    6-8周
    规格
    数量
  • EVT-101 HCl
    T712901189088-41-2
    EVT-101 is a GluN2B antagonist, binding at the same GluN1/GluN2B dimer interface as ifenprodil but adopting a remarkably different binding mode involving a distinct subcavity and receptor interactions.
    • ¥ 11700
    6-8周
    规格
    数量
  • Intepirdine
    SB 742457, RVT-101, GSK-742457
    T1774607742-69-8
    Intepirdine (GSK-742457) 是5-HT6受体拮抗剂,pKi 为9.63,用于研究阿尔茨海默病治疗的试验。
    • ¥ 147
    In Stock
    规格
    数量
    TargetMol | Citations 客户已引用
  • Mvt 101
    Mvt-101, Mvt101
    T24509125552-93-4
    Mvt 101 is a peptide inhibitor.
    • 待询
    规格
    数量
  • Phenylbutazone-d9
    T712881189479-75-1
    Phenylbutazone-d9 is intended for use as an internal standard for the quantification of phenylbutazone by GC- or LC-MS. Phenylbutazone is a non-steroidal anti-inflammatory drug and an inhibitor of the peroxidase activity of COX (IC50 = ~100 µM in the presence of hydrogen peroxide). It also inhibits prostaglandin I synthase (IC50 = ~25 µM in the presence of hydrogen peroxide). Phenylbutazone (2 mg/kg) reduces increases in type II collagen levels in the inflamed joints of an equine model of LPS-induced acute synovitis. Formulations containing phenylbutazone have been used in the treatment of lameness in horses.
    • ¥ 2970
    35日内发货
    规格
    数量
  • VT-ME6
    T709001353880-00-8
    VT-ME6 is a potent and selective sphingosine kinase 2 inhibitor. VT-ME6, contained a quaternary ammonium group as a warhead and established that a positively charged moiety is necessary for engaging key amino acid residues in the enzyme binding pocket.13,14 This compound is moderately potent (Ki = 8 lM) and displays three-fold selectivity for SphK2 over SphK1. Sphingosine-1-phosphate (S1P) is a ubiquitous, endogenous small molecule that is synthesized by two isoforms of sphingosine kinase (SphK1 and 2). Intervention of the S1P signaling pathway has attracted significant attention because alteration of S1P levels is linked to several disease states including cancer, fibrosis, and sickle cell disease.
    • ¥ 10600
    6-8周
    规格
    数量